We use cookies for a better user experience. Read our Privacy Policy

I Agree

Needle Biopsy Market Trends, 2020-2030

Needle Biopsy Market (Type: Fine-needle Aspiration Biopsy and Core Needle Biopsy; Application: Breast Cancer, Thyroid Cancer, Prostate Cancer, Liver Cancer, and Others; and End User: Hospital, Diagnostics & Imaging Centers, Research Laboratories & Academic Institutes, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

High Focus on Improving Visibility of Biopsy Needles to Aid Market Growth

In the past decade, improved awareness and knowledge of cancers coupled with longer life expectancy has played a key role in augmenting the demand for needle biopsies. Advancements in cancer diagnosis and major developments in the medical sector have primarily contributed to the increasing adoption of biopsy needles due to which, the needle biopsy market is projected to witness steady growth during the forecast period. Furthermore, increasing demand for biopsy needles with improved visibility in image guidance procedures, including ultrasound, is expected to propel the demand for biopsy needles.

The demand for biopsy needles is on the rise due to improved visibility and positional accuracy– a factor that is likely to propel the global biopsy needles market during the forecast period. A large number of players involved in the needle biopsy market are increasingly focusing on launching innovative biopsy needles with high visibility. In addition, market players are increasingly focusing on minimizing the deflection of needles in needle biopsy procedures. The increasing demand for interventional medical procedures around the world is anticipated to provide lucrative opportunities for players involved in the current needle biopsy market during the forecast period.

At the back of these factors, along with increasing demand for minimally invasive and accurate biopsies, the global needle biopsy market is projected to cross a market value of US$ 1.2 Bn by the end of 2030.

Request a sample to get extensive insights into the Needle Biopsy Market

Surge in Number of Cancer Cases Worldwide to Drive Market

The needle biopsy procedure is primarily deployed to diagnose prostate, skin, and breast cancer. Over the past couple of decades, the exponential rise in the number of cancer patients around the world is one of the primary factors due to which, the demand for needle biopsy has witnessed impressive growth. Moreover, the increasing demand for minimally invasive needle biopsy procedures is another major factor anticipated to augment the demand for needle biopsy during the forecast period. A notable surge in the number of breast cancer patients is expected to provide a massive boost to the adoption of needle biopsy procedures. This is another factor that is likely to provide considerable boost to the overall growth of the needle biopsy market during the forecast period.

Furthermore, the growing need to detect early signs of a preventable disease to improve survival rates of patients is another factor due to which, the demand for needle biopsy is on the rise.

Market players are increasingly focusing on research and development activities and other innovative techniques to improve the overall success rate of needle biopsy procedures. For instance, a new type of needle biopsy is currently being developed by a team of researchers as part of the Aalto University project– AdvaNeedle. The research primarily aims to address drawbacks of the current thick-and-fine-needle samples by minimizing pain and inadequate diagnosis.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Demand to Remain Steady During COVID-19 Pandemic

The COVID-19 pandemic has derailed the growth of several core industries as a result of stringent lockdowns and restrictions on transportation and trade. However, the medical sector is likely to largely remain unaffected due to the COVID-19 crisis, as manufacturing of medical devices, drugs, and medication are classified as ‘essential goods and services’. The demand for needle biopsy procedures has remained steady throughout 2020. Thus, the needle biopsy market is expected to exhibit a steady growth. Although the number of non-critical procedures has witnessed significant decline, the demand for minimally invasive needle biopsy procedures is expected to provide considerable boost to the overall prospects of the needle biopsy market in 2020.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Needle Biopsy Market

Analysts’ Viewpoint

The global needle biopsy market is expected to expand at a healthy CAGR of 7% during the forecast period. The market growth can be attributed to increasing prevalence of cancer worldwide, research and development activities, technological advancements, and high demand for minimally invasive needle biopsy procedures. Market players should focus on improving various physical and functional parameters of biopsy needles to gain a competitive edge in the current market landscape.

Needle Biopsy Market: Overview

  • According to Transparency Market Research’s latest report on the global needle biopsy market for the historical period 2018–2019 and forecast period 2020–2030, increase in incidence of cancer across the globe, rise in global geriatric population, and government initiatives to spread awareness about cancer are expected to drive the global market during the forecast period
  • According to the report, the needle biopsy market was valued at ~US$ 630 Mn in 2019. It is anticipated to expand at a CAGR of 7% from 2020 to 2030. In terms of volume, around 19,351,640 biopsy needles were used in 2019, and the number is projected to reach at 33,683,957 by the end of 2030.

Increase in Incidence of Cancer Worldwide: Key Drivers

  • High prevalence and rise in incidence rate of cancer across the globe are likely to propel the market during the forecast period
  • Cancer is the second-leading cause of death worldwide. In 2018, around 9.6 million deaths were estimated to have occurred globally due to cancer. Of every six deaths globally, around one death is due to cancer.
  • According to WHO, globally, around 782,000 deaths were caused due to liver cancer in 2018. It is the sixth-most commonly occurring cancer worldwide.
  • Moreover, according to the World Cancer Research Fund, in 2018, globally, around 567,233 cases of thyroid cancer were reported, accounting for 3.3% of all cancer cases

Increase in Geriatric Population to Boost Market

  • Rapidly ageing population that are more prone to chronic medical conditions, especially cancer, is estimated to drive the market during the forecast period
  • According to the World Health Organization, the geriatric population (people aged above 60) is expected to double by 2050, from 962 million in 2017 to 2 billion in 2050. Globally, the geriatric population is increasing at a rapid pace as compared to that of the young population.
  • The geriatric population is more susceptible to various cancers, especially breast cancer and prostate cancer
  • Breast cancer commonly occurs in women of over 40 years. According to a recent article published by the National Cancer Institute, U.S., reviewed on September, 2012, 12.4% women born in the U.S. are likely to develop breast cancer in their lifetime, i.e., one among eight women would be diagnosed with breast cancer.
  • According to the American Society of Clinical Oncology (ASCO), more than 80% of prostate cancer cases are diagnosed in people who are aged 65 years and older
  • Thus, rapid increase in the geriatric population across the globe is a prominent factor that is expected to boost the needle biopsy market during the forecast period

Availability of Alternative Biopsies for Disease Diagnosis to Hamper Market

  • Liquid biopsy procedure holds significant potential for the diagnosis of a wide range of diseases and cancer. The method is a minimally invasive procedure and easy to perform compared to conventional needle biopsy.
  • Presently, R&D on cancer diagnosis is primarily focused on liquid biopsy. Market players and research institutes are conducting extensive clinical trials to develop highly sensitive biopsy platforms.
  • In May 2018, Grail, a U.S.-based biotechnology company, raised US$ 1 Bn in VC funding and embarked on a 120,000-patient study for early breast cancer detection
  • In January 2018, researchers at Johns Hopkins developed a test called CancerSEEK, which is a non-invasive multianalyte test that analyzes levels of eight cancer proteins and presence of cancer gene mutation in circulating DNA in blood. The test included more than 1,000 patients with non-metastatic, stages I to III cancers of the ovary, stomach, liver, pancreas, esophagus, lungs, colorectum, and breast.
  • Thus, extensive research on liquid biopsy aimed at promoting early and non-invasive diagnosis in cancer is likely to restrain the needle biopsy market during the forecast period

Needle Biopsy Market: Competition Landscape

  • This report profiles major players in the global needle biopsy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global needle biopsy market is highly consolidated, with few players holding majority of market share in global market
  • Leading players operating in the global needle biopsy market include
    • Becton
    • Dickinson and Company
    • Merit Medical Systems, Inc.
    • Argon Medical and Olympus Corporation
    • INRAD, Inc.
    • Argon Medical
    • CONMED Corporation
    • Stryker Corporation
    • Medtronic plc

Needle Biopsy Market: Key Developments

  • Key players in the global needle biopsy market are engaged in regulatory approvals, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the global needle biopsy market. A few expansion strategies adopted by players operating in the global needle biopsy market are:
  • In May 2019, Argon Medical acquired Mana-Tech, Ltd., its exclusive distributor for the U.K. and Ireland. This acquisition strengthened the company’s distribution network in Europe.
  • In August 2017, Hologic, Inc. launched the Brevera breast biopsy system with CorLumina imaging technology in the U.S. The biopsy system is designed to increase biopsy accuracy with real-time imaging to provide valuable information at point of care.
  • In November 2017, Merit Medical Systems, Inc. entered into a definitive agreement to acquire Becton Dickinson and Company’s soft tissue core needle biopsy product line and Aspira product line of tunneled home drainage catheters and accessories. The total agreement was worth US$ 100 Mn.
  • The report on the global needle biopsy market discussed individual strategies, followed by company profiles of manufacturers of needle biopsy. The competition landscape section has been included in the report to provide readers with a dashboard view of key players operating in the global needle biopsy market.

Needle Biopsy Market – Segmentation

Type

Fine-needle Aspiration Biopsy

Core Needle Biopsy

Application

Breast Cancer

Thyroid Cancer

Prostate Cancer

Transperineal

Transrectal

Liver Cancer

Other

End User

Hospital

Diagnostics & Imaging Centers

Research Laboratories & Academic Institutes

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Needle Biopsy Market Trends, 2020-2030

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of needle biopsy market?

Needle biopsy market to cross valuation of US$ 1.2 Bn by 2030

What is the anticipated CAGR of the needle biopsy market in the forecast period?

Needle biopsy market is anticipated to expand at a CAGR of 7% from 2020 to 2030

What are the key driving factors for the growth of the needle biopsy market?

Needle biopsy market is driven by rise in prevalence of human and animal cancer across the globe

Which region is expected to project the highest market share in the global needle biopsy market?

North America accounted for a major share of the global needle biopsy market and the trend is anticipated to continue during the forecast period

Who are the key players in the global needle biopsy market?

Key players in the global needle biopsy market include Becton, Dickinson and Company, Merit Medical Systems, Inc., Argon Medical and Olympus Corporation, INRAD, Inc.

1. Preface

    1.1. Market  Definition and Scope

    1.2. Market  Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Needle Biopsy Market

4. Market  Overview

    4.1. Introduction

        4.1.1. Market  Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market  Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Needle Biopsy Market Analysis and Forecast, 2018–2030

        4.4.1. Market  Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

    5.1. Disease Prevalence & Incidence Rate globally with key countries

    5.2. Overview of the Image Guided Needle Biopsy

    5.3. Regulatory Scenario by Region/globally

    5.4. COVID-19 Pandemics Impact on Global Needle Biopsy Market

6. Global Needle Biopsy Market Analysis and Forecast, by Type   

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Needle Biopsy Market Value & Volume Forecast, by Type, 2018–2030

        6.3.1. Fine-Needle Aspiration Biopsy

        6.3.2. Core Needle Biopsy

    6.4. Market Attractiveness Analysis, by Type

7.   Global Needle Biopsy Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Needle Biopsy Market Value Forecast, by Application, 2018–2030

        7.3.1. Breast Cancer

        7.3.2. Thyroid Cancer

        7.3.3. Prostate Cancer

            7.3.3.1. Transperineal

            7.3.3.2. Transrectal

        7.3.4. Liver Cancer

        7.3.5. Others

    7.4. Market  Attractiveness Analysis, by Application

8. Global Needle Biopsy Market Analysis and Forecast, by End-user  

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        8.3.1. Hospitals

        8.3.2. Diagnostics and Imaging Centers

        8.3.3. Research Laboratories and Academic Institutes

        8.3.4. Others

    8.4. Market  Attractiveness Analysis, by End-user

9. Global Needle Biopsy Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Needle Biopsy Market Value Forecast, by Region

        9.2.1. Europe

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market  Attractiveness Analysis, by Region

10. North America   Needle Biopsy Market Analysis and Forecast

    10.1.  Introduction

        10.1.1.  Key Findings

    10.2.  North America Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        10.2.1. Fine-Needle Aspiration Biopsy

        10.2.2. Core Needle Biopsy

    10.3. North America Needle Biopsy Market Value Forecast, by Application, 2018–2030

        10.3.1. Breast Cancer

        10.3.2. Thyroid Cancer

        10.3.3. Prostate Cancer

            10.3.3.1. Transperineal

            10.3.3.2. Transrectal

        10.3.4. Liver Cancer

        10.3.5. Others

    10.4. North America Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        10.4.1. Hospitals

        10.4.2. Diagnostics and Imaging Centers

        10.4.3. Research Laboratories and Academic Institutes

        10.4.4. Others

    10.5. North America Needle Biopsy Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Needle Biopsy Market Attractiveness Analysis

        10.6.1. By Type   

        10.6.2. By Application   

        10.6.3. By End-user  

        10.6.4. By Country

11. Europe Needle Biopsy Market Analysis and Forecast

    11.1.  Introduction

        11.1.1.  Key Findings

    11.2.  Europe Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        11.2.1. Fine-Needle Aspiration Biopsy

        11.2.2. Core Needle Biopsy

    11.3. Europe Needle Biopsy Market Value & Volume Forecast, by Application, 2018–2030

        11.3.1. Breast Cancer

        11.3.2. Thyroid Cancer

        11.3.3. Prostate Cancer

            11.3.3.1. Transperineal

            11.3.3.2. Transrectal

        11.3.4. Liver Cancer

        11.3.5. Others

    11.4. Europe Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        11.4.1. Hospitals

        11.4.2. Diagnostics and Imaging Centers

        11.4.3. Research Laboratories and Academic Institutes

        11.4.4. Others

    11.5. Europe Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Needle Biopsy Market Attractiveness Analysis

        11.6.1. By Type   

        11.6.2. By Application   

        11.6.3. By End-user  

        11.6.4. By Country/Sub-region

12. Asia Pacific Needle Biopsy Market Analysis and Forecast

    12.1.  Introduction

        12.1.1.  Key Findings

    12.2.  Asia Pacific Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        12.2.1. Fine-Needle Aspiration Biopsy

        12.2.2. Core Needle Biopsy

    12.3. Asia Pacific Needle Biopsy Market Value Forecast, by Application, 2018–2030

        12.3.1. Breast Cancer

        12.3.2. Thyroid Cancer

        12.3.3. Prostate Cancer

            12.3.3.1. Transperineal

            12.3.3.2. Transrectal

        12.3.4. Liver Cancer

        12.3.5. Others

    12.4. Asia Pacific Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        12.4.1. Hospitals

        12.4.2. Diagnostics and Imaging Centers

        12.4.3. Research Laboratories and Academic Institutes

        12.4.4. Others

    12.5. Asia Pacific Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030

        12.5.1. China

        12.5.2. India

        12.5.3. Japan

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Needle Biopsy Market Attractiveness Analysis

        12.6.1. By Type   

        12.6.2. By Application   

        12.6.3. By End-user  

        12.6.4. By Country/Sub-region

13. Latin America Needle Biopsy Market Analysis and Forecast

    13.1.  Introduction

        13.1.1.  Key Findings

    13.2.  Latin America Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        13.2.1. Fine-Needle Aspiration Biopsy

        13.2.2. Core Needle Biopsy

    13.3. Latin America Needle Biopsy Market Value Forecast, by Application, 2018–2030

        13.3.1. Breast Cancer

        13.3.2. Thyroid Cancer

        13.3.3. Prostate Cancer

            13.3.3.1. Transperineal

            13.3.3.2. Transrectal

        13.3.4. Liver Cancer

        13.3.5. Others

    13.4. Latin America Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        13.4.1. Hospitals

        13.4.2. Diagnostics and Imaging Centers

        13.4.3. Research Laboratories and Academic Institutes

        13.4.4. Others

    13.5. Latin America Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Needle Biopsy Market Attractiveness Analysis

        13.6.1. By Type   

        13.6.2. By Application   

        13.6.3. By End-user  

        13.6.4. By Country/Sub-region

14. Middle East & Africa Needle Biopsy Market Analysis and Forecast

    14.1.  Introduction

        14.1.1.  Key Findings

    14.2.  Middle East & Africa Needle Biopsy Market Value  & Volume Forecast, by Type, 2018–2030

        14.2.1. Fine-Needle Aspiration Biopsy

        14.2.2. Core Needle Biopsy

    14.3. Middle East & Africa Needle Biopsy Market Value Forecast, by Application, 2018–2030

        14.3.1. Breast Cancer

        14.3.2. Thyroid Cancer

        14.3.3. Prostate Cancer

            14.3.3.1. Transperineal

            14.3.3.2. Transrectal

        14.3.4. Liver Cancer

        14.3.5. Others

    14.4. Middle East & Africa Needle Biopsy Market Value Forecast, by End-user, 2018–2030

        14.4.1. Hospitals

        14.4.2. Diagnostics and Imaging Centers

        14.4.3. Research Laboratories and Academic Institutes

        14.4.4. Others

    14.5. Middle East & Africa Needle Biopsy Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Needle Biopsy Market Attractiveness Analysis

        14.6.1. By Type   

        14.6.2. By Application   

        14.6.3. By End-user  

        14.6.4. By Country/Sub-region

15. Competitive Landscape

    15.1. Market  Player – Competition Matrix (By Tier and Size of companies)

    15.2. Company Share Analysis

    15.3.  Company Profiles

        15.3.1. Hologic, Inc.

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Financial Overview

            15.3.1.3. Product Portfolio

            15.3.1.4. Strategic Overview

            15.3.1.5. SWOT Analysis

        15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company).

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Financial Overview

            15.3.2.3. Product Portfolio

            15.3.2.4. Strategic Overview

            15.3.2.5. SWOT Analysis

        15.3.3.  INRAD, Inc.

            15.3.3.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Financial Overview

            15.3.3.3. Product Portfolio

            15.3.3.4. Strategic Overview

            15.3.3.5. SWOT Analysis

        15.3.4.  Argon Medical

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Financial Overview

            15.3.4.3. Product Portfolio

            15.3.4.4. Strategic Overview

            15.3.4.5. SWOT Analysis

        15.3.5. CONMED Corporation

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Financial Overview

            15.3.5.3. Product Portfolio

            15.3.5.4. Strategic Overview

            15.3.5.5. SWOT Analysis

        15.3.6. Olympus Corporation

            15.3.6.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Financial Overview

            15.3.6.3. Product Portfolio

            15.3.6.4. Strategic Overview

            15.3.6.5. SWOT Analysis

        15.3.7. Stryker Corporation

            15.3.7.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. Strategic Overview

            15.3.7.5. SWOT Analysis

        15.3.8.  Medtronic plc

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Financial Overview

            15.3.8.3. Product Portfolio

            15.3.8.4. Strategic Overview

            15.3.8.5. SWOT Analysis

        15.3.9. Merit Medical Systems, Inc.

            15.3.9.1.  Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Financial Overview

            15.3.9.3. Product Portfolio

            15.3.9.4. Strategic Overview

            15.3.9.5. SWOT Analysis

List of Tables

Table 01: Global Needle Biopsy Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 02: Global Needle Biopsy Market Volume (Units) Forecast, by Type, 2018–2030

Table 03: Global Needle Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 04: Global Needle Biopsy Market Value (US$ Mn) Forecast, by Prostate Cancer, 2018–2030

Table 05: Global Needle Biopsy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 06: Global Needle Biopsy Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 07: North America Needle Biopsy Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 08: North America Needle Biopsy Market Volume (Units) Forecast, by Type, 2018–2030

Table 09: North America Needle Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 10: North America Needle Biopsy Market Value (US$ Mn) Forecast, by Prostate Cancer, 2018–2030

Table 11: North America Needle Biopsy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 12: North America Needle Biopsy Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 13: Europe Needle Biopsy Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 14: Europe Needle Biopsy Market Volume (Units) Forecast, by Type, 2018–2030

Table 15: Europe Needle Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 16: Europe Needle Biopsy Market Value (US$ Mn) Forecast, by Prostate Cancer, 2018–2030

Table 17: Europe Needle Biopsy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 18: Europe Needle Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 19: Asia Pacific Needle Biopsy Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 20: Asia Pacific Needle Biopsy Market Volume (Units) Forecast, by Type, 2018–2030

Table 21: Asia Pacific Needle Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 22: Asia Pacific Needle Biopsy Market Value (US$ Mn) Forecast, by Prostate Cancer, 2018–2030

Table 23: Asia Pacific Needle Biopsy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 24: Asia Pacific Needle Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 25: Latin America Needle Biopsy Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 26: Latin America Needle Biopsy Market Volume (Units) Forecast, by Type, 2018–2030

Table 27: Latin America Needle Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 28: Latin America Needle Biopsy Market Value (US$ Mn) Forecast, by Prostate Cancer, 2018–2030

Table 29: Latin America Needle Biopsy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 30: Latin America Needle Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 31: Middle East & Africa Needle Biopsy Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 32: Middle East & Africa Needle Biopsy Market Volume (Units) Forecast, by Type, 2018–2030

Table 33: Middle East & Africa Needle Biopsy Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 34: Middle East & Africa Needle Biopsy Market Value (US$ Mn) Forecast, by Prostate Cancer, 2018–2030

Table 35: Middle East & Africa Needle Biopsy Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 36: Middle East & Africa Needle Biopsy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

List of Figures

Figure 01: Global Needle Biopsy Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Needle Biopsy Market Volume (Units) Forecast, 2018–2030

Figure 03: Global Needle Biopsy Market Value Share, by End-user, 2019

Figure 04: Global Needle Biopsy Market Value Share, by Region, 2019

Figure 05: Global Biopsy Market Value Share, by Type, 2019

Figure 06: Global Needle Biopsy Market Value Share, by Application, 2019

Figure 07: Global Needle Biopsy Market Value Share Analysis, by Type, 2019 and 2030

Figure 08: Global Needle Biopsy Market Attractiveness Analysis, by Type, 2020 and 2030

Figure 09: Global Needle Biopsy Market  Value (US$ Mn), by Fine-Needle Aspiration Biopsy, 2018–2030

Figure 10: Global Needle Biopsy Market  Value (US$ Mn), by Core Needle Biopsy, 2018–2030

Figure 11: Global Needle Biopsy Market Value Share Analysis, by Application, 2019 and 2030

Figure 12: Global Needle Biopsy Market Attractiveness Analysis, by Application, 2020 and 2030

Figure 13: Global Needle Biopsy Market Value (US$ Mn), by Breast Cancer, 2018–2030

Figure 14: Global Needle Biopsy Market Value (US$ Mn), by Thyroid Cancer, 2018–2030

Figure 15: Global Needle Biopsy Market Value (US$ Mn), by Prostate Cancer, 2018–2030

Figure 16: Global Needle Biopsy Market Value (US$ Mn), by Liver Cancer, 2018–2030

Figure 17: Global Needle Biopsy Market Value (US$ Mn), by Others, 2018–2030

Figure 18: Global Needle Biopsy Market Value Share Analysis, by End-user, 2019 and 2030

Figure 19: Global Needle Biopsy Market Attractiveness Analysis, by End-user, 2020 and 2030

Figure 20: Global Needle Biopsy Market Value (US$ Mn), by Hospitals, 2018–2030

Figure 21: Global Needle Biopsy Market Value (US$ Mn), by Diagnostics & Imaging Centers, 2018–2030

Figure 22: Global Needle Biopsy Market Value (US$ Mn), by Research Laboratories & Academic Institutes, 2018–2030

Figure 23: Global Needle Biopsy Market Value (US$ Mn), by Others, 2018–2030

Figure 24: Global Needle Biopsy Market Value Share Analysis, by Region, 2019 and 2030

Figure 25: Global Needle Biopsy Market Attractiveness Analysis, by Region, 2020 and 2030

Figure 26: North America Needle Biopsy Market Value (US$ Mn) and Volume (Units) Forecast, 2018–2030

Figure 27: North America Needle Biopsy Market Value Share Analysis, by Type, 2019 and 2030

Figure 28: North America Needle Biopsy Market Attractiveness Analysis, by Type, 2020–2030

Figure 29: North America Needle Biopsy Market Value Share Analysis, by Application, 2019 and 2030

Figure 30: North America Needle Biopsy Market Attractiveness Analysis, by Application, 2020–2030

Figure 31: North America Needle Biopsy Market Value Share Analysis, by End-user, 2019 and 2030

Figure 32: North America Needle Biopsy Market Attractiveness Analysis, by End-user, 2020–2030

Figure 33: North America Needle Biopsy Market Value Share Analysis, by Country, 2019 and 2030

Figure 34: North America Needle Biopsy Market Attractiveness Analysis, by Country, 2020–2030

Figure 35: Europe Needle Biopsy Market Value (US$ Mn) and Volume (Units) Forecast, 2018–2030

Figure 36: Europe Needle Biopsy Market Value Share Analysis, by Type, 2019 and 2030

Figure 37: Europe Needle Biopsy Market Attractiveness Analysis, by Type, 2020–2030

Figure 38: Europe Needle Biopsy Market Value Share Analysis, by Application, 2019 and 2030

Figure 39: Europe Needle Biopsy Market Attractiveness Analysis, by Application, 2020–2030

Figure 40: Europe Needle Biopsy Market Value Share Analysis, by End-user, 2019 and 2030

Figure 41: Europe Needle Biopsy Market Attractiveness Analysis, by End-user, 2020–2030

Figure 42: Europe Needle Biopsy Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 43: Europe Needle Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 44: Asia Pacific Needle Biopsy Market Value (US$ Mn) and Volume (Units) Forecast, 2018–2030

Figure 45: Asia Pacific Needle Biopsy Market Value Share Analysis, by Type, 2019 and 2030

Figure 46: Asia Pacific Needle Biopsy Market Attractiveness Analysis, by Type, 2020–2030

Figure 47: Asia Pacific Needle Biopsy Market Value Share Analysis, by Application, 2019 and 2030

Figure 48: Asia Pacific Needle Biopsy Market Attractiveness Analysis, by Application, 2020–2030

Figure 49: Asia Pacific Needle Biopsy Market Value Share Analysis, by End-user, 2019 and 2030

Figure 50: Asia Pacific Needle Biopsy Market Attractiveness Analysis, by End-user, 2020–2030

Figure 51: Asia Pacific Needle Biopsy Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 52: Asia Pacific Needle Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 53: Latin America Needle Biopsy Market Value (US$ Mn) and Volume (Units) Forecast, 2018–2030

Figure 54: Latin America Needle Biopsy Market Value Share Analysis, by Type, 2019 and 2030

Figure 55: Latin America Needle Biopsy Market Attractiveness Analysis, by Type, 2020–2030

Figure 56: Latin America Needle Biopsy Market Value Share Analysis, by Application, 2019 and 2030

Figure 57: Latin America Needle Biopsy Market Attractiveness Analysis, by Application, 2020–2030

Figure 58: Latin America Needle Biopsy Market Value Share Analysis, by End-user, 2019 and 2030

Figure 59: Latin America Needle Biopsy Market Attractiveness Analysis, by End-user, 2020–2030

Figure 60: Latin America Needle Biopsy Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 61: Latin America Needle Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 62: Middle East & Africa Needle Biopsy Market Value (US$ Mn) and Volume (Units) Forecast, 2018–2030

Figure 63: Middle East & Africa Needle Biopsy Market Value Share Analysis, by Type, 2019 and 2030

Figure 64: Middle East & Africa Needle Biopsy Market Attractiveness Analysis, by Type, 2020–2030

Figure 65: Middle East & Africa Needle Biopsy Market Value Share Analysis, by Application, 2019 and 2030

Figure 66: Middle East & Africa Needle Biopsy Market Attractiveness Analysis, by Application, 2020–2030

Figure 67: Middle East & Africa Needle Biopsy Market Value Share Analysis, by End-user, 2019 and 2030

Figure 68: Middle East & Africa Needle Biopsy Market Attractiveness Analysis, by End-user, 2020–2030

Figure 69: Middle East & Africa Needle Biopsy Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 70: Middle East & Africa Needle Biopsy Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 71: Global Needle Biopsy Market Company Share Analysis

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

817

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved